medigraphic.com
ISSN 1726-6718 (Electronic)
Revista Cubana de Anestesiología y Reanimación

2019, Number 3

<< Back Next >>

Revista Cubana de Anestesiología y Reanimación 2019; 18 (3)

Assessment of magnesium sulfate in bronchospasm treatment

Colmenares SF, Pozo RJA

Language: Spanish
References: 12
Page: 1-10
PDF size: 246.75 Kb.


ABSTRACT

Introduction: One of the most feared emergencies during the instrumentation of the respiratory tract is bronchospasm. Magnesium sulfate, administered intravenously, has a bronchodilation effect by antagonizing calcium channels, inhibiting muscle contraction mediated by calcium and promoting bronchial smooth muscle relaxation.
Objective: To evaluate the efficacy of magnesium sulfate administered intravenously in patients with bronchospasm during bronchoscopy.
Methods: Observational, descriptive and cross-sectional study carried out with 20 patients, with bronchospasm, triggered by airway manipulation with flexible bronchoscope, treated with 50 mg/kg of magnesium sulfate, (maximum 2 g), administered intravenously for 5 min.
Results: Men between 50-59 years (75%) predominated. All patients were smokers. 15 patients were classified with physical state ASA III. They suffered bronchospasm of mild intensity 60%, classified according to the clinic and monitoring of oxygen saturation. In 75% of the patients, the bronchospasm ceased after the treatment without administering any other medication. No adverse effects were recorded. No patient needed orotracheal intubation for ventilation or required hospitalization for more than 8 hours.
Conclusions: Magnesium sulfate is a good pharmacological option for the emergency treatment of bronchospasm triggered by manipulation of the respiratory tract.


REFERENCES

  1. Braun Saro B, Duffort Falcó M, Fernández Ormaechea I, Alcorta Mesas A. Broncoespasmo. Extractos de Medicine. 2007[acceso: 23/12/2018];09:5817-9. Disponible en: http://apuntesmedicos.net/2008/06/05/protocolo-de-manejo-del-broncoespasmo/

  2. Carrera M, Cosio BG, Agustí A. Tratamiento hospitalario de los episodios de agudización de la EPOC. Una revisión basada en la evidencia. Arch Bronconeumol. 2005[acceso: 13/01/2019];41:220-29. Disponible en: http://www.archbronconeumol.org/es-tratamiento-hospitalario-los-episodios-agudizacion-articulo-13073172

  3. NICE. Chronic Obstructive pulmonary disease. Thorax. 2004;59(Supp):232.

  4. Abreu González J. Efecto del sulfato de magnesio intravenoso en la exacerbación de la EPOC que precisa hospitalización: Estudio aleatorizado controlado con placebo. Arch Bronconeumol. 2006[acceso: 15/02/2018];42(8):384-7 Disponible en: https://www.archbronconeumol.org/es-efecto-del-sulfato-magnesio-intravenoso-articulo-13091646

  5. Loria Castellanos J, Hinojosa Aguilar IN, Montiel Jarquín JA, Cruz Vega F. Sulfato de magnesio inhalado en el tratamiento del asma aguda. Pren. Méd. Argent. 2017[acceso: 20/03/2018];103(4): 200-09 Disponible en: https://www.researchgate.net/publication/318380646_Sulfato_de_magnesio_inhalado_en_el_tratamiento_del_asma_aguda

  6. Hirota K, Yamakage M, Hashimoto S, Asai T, Isono S. Perioperative respiratory complications: current evidence and strategy discussed in 2017 JA symposium. J Anesth. 2018;32(1):132-36.

  7. Goodacre S, Cohen J, Bradburn M, Gray A, Benger J, Coats T. The 3Mg trial: a randomized controlled trail of intravenous or nebulised magnesium sulphate versus placebo in adults with severe. The Lancet. 2013[acceso: 13/01/2019];1:293-300. Disponible en: http://dx.doi.org/10.1016/S2213-2600(13)70070-5

  8. Shan Z, Rong Y, Yang W, Wang D, Yao P, Xie J, et al. Intravenous and nebulized magnesium sulfate for treating acute asthma in adults and children: A systematic review and meta-analysis. Respiratory Medicine. 2013[acceso: 23/02/2019];107(3):321-30. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/23290189

  9. Steen B. Manejo de la crisis de asma en urgencias. Rev Patol Respir. 2007[acceso: 24/02/2019];10(4): 209-212 Disponible en: https://www.revistadepatologiarespiratoria.org/descargas/pr_10-4_209-212.pdf

  10. Romero Bonilla J. Uso del sulfato de magnesio de crisis asmáticas que no responden a salbutamol. Rev Med Costa Rica. 2014[acceso: 23/02/2019],609:145-48. Disponible en: www.medigraphic.com/pdfs/revmedcoscen/rmc-2014/rmc141x.pdf

  11. Blitz M, Blitz S, Beasely R, Diner BM, Hughes R, Knopp JA, et al. Inhaled magnesium sulfate in the treatment for acute asthma. Cochrane Database Syst Rev. 2005;(4):CD003898.

  12. Looseley A. Manejo de broncoespasmo durante la anestesia general. Update in Anaesthesia. 2011[acceso: 23/02/2019];27(1):18-22. Disponible en www.anaesthesiologists.org




2020     |     www.medigraphic.com